−126.48 USD
−1.82 M USD
0.00 USD
11.60 M
About PROPANC BIOPHARMA INC
Sector
Industry
CEO
James Andrew Nathanielsz
Website
Headquarters
Camberwell
Founded
2007
Propanc Biopharma, Inc. is a development-stage healthcare company, which engages in the research and development of cancer treatments. The firm focuses on the treatment of pancreatic, ovarian, and colorectal cancer. It offers its product pipeline, including PRP and POP1. The company was founded by James Nathanielsz and Julian Kenyon on October 15, 2007 and is headquartered in Camberwell, Australia.
Related stocks
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of PPCB is 2.87 USD — it has decreased by −72.40% in the past 24 hours. Watch PROPANC BIOPHARMA INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange PROPANC BIOPHARMA INC stocks are traded under the ticker PPCB.
PPCB stock has fallen by −59.58% compared to the previous week, the month change is a −17.05% fall, over the last year PROPANC BIOPHARMA INC has showed a −100.00% decrease.
PPCB stock is 268.79% volatile and has beta coefficient of −2.29. Track PROPANC BIOPHARMA INC stock price on the chart and check out the list of the most volatile stocks — is PROPANC BIOPHARMA INC there?
Yes, you can track PROPANC BIOPHARMA INC financials in yearly and quarterly reports right on TradingView.
PPCB net income for the last quarter is −54.07 M USD, while the quarter before that showed −430.18 K USD of net income which accounts for −12.47 K% change. Track more PROPANC BIOPHARMA INC financial stats to get the full picture.
No, PPCB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Aug 17, 2025, the company has 2 employees. See our rating of the largest employees — is PROPANC BIOPHARMA INC on this list?
Like other stocks, PPCB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PROPANC BIOPHARMA INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PROPANC BIOPHARMA INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PROPANC BIOPHARMA INC stock shows the sell signal. See more of PROPANC BIOPHARMA INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.